Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients

Inclusion Criteria: * Male and female patients from the age of 4 years * Confirmed diagnosis of epilepsy requiring AED treatment * Patients already receiving daily AED treatment as a monotherapy or a polytherapy with maximum 2 AEDs within the terms of marketing authorization with the following medications: Carbamazepine, Clobazam, Clonazepam, Gabapentin, Lamotrigine, Levetiracetam, Oxcarbazepine, Phenobarbital, Phenytoin, Pregabalin, Tiagabine, Topiramate, Valproate, Zonisamide * Treatment must be stable for at least 3 months prior to assessment * Absence of other severe and/or uncontrolled symptomatic chronic illness